UPMC Hillman Cancer Center Erie — Erie, Pennsylvania

UPMC Hillman Cancer Center Erie is a clinical research site located in Erie, Pennsylvania, United States 16505.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

UPMC Hillman Cancer Center Erie has participated in 109 clinical trials with 94 currently active.

Therapeutic areas: Refractory Differentiated Thyroid Gland Carcinoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7.

Sponsors: ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI), SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPMC Hillman Cancer Center Erie?

UPMC Hillman Cancer Center Erie has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPMC Hillman Cancer Center Erie conducted?

UPMC Hillman Cancer Center Erie has 109 clinical trials on record, with 94 currently active. Their work covers Refractory Differentiated Thyroid Gland Carcinoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7.

Is UPMC Hillman Cancer Center Erie accredited by Crixeo Health?

Yes — UPMC Hillman Cancer Center Erie holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about UPMC Hillman Cancer Center Erie?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.